SCHEMBL7467972

SCHEMBL7467972

CSc1nccc(C(=O)C(CC(=O)C2CCN(C(=O)OCc3ccccc3)CC2)c2cccc(C(F)(F)F)c2)n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.41
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
CYP2C19 P33261 1/20 0.40
CHRM2 P08172 1/20 0.39
CHRM4 P08173 1/20 0.39
CHRM3 P20309 1/20 0.39
HTT P42858 1/20 0.39
GRIN2B Q13224 7/20 0.37
TRPV4 Q9HBA0 1/20 0.37
FAAH O00519 1/20 0.37
LNPEP Q9UIQ6 1/20 0.37
F2R P25116 1/20 0.36
CETP P11597 1/20 0.36
TACR1 P25103 1/20 0.36
BCL9 O00512 1/20 0.35
CTNNB1 P35222 1/20 0.35
CYP2D6 P10635 3/20 0.35
CYP2C9 P11712 3/20 0.35
CYP3A4 P08684 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7672577 0.83 SMN1; SMN2 (0.46) SMN1; SMN2NPC1RAB9ACYP2C19CHRM2
SCHEMBL7679543 0.80 SMN1; SMN2 (0.43) SMN1; SMN2NPC1RAB9ACYP2C19CHRM2
SCHEMBL6950463 0.78 SMN1; SMN2 (0.46) SMN1; SMN2NPC1RAB9ACYP2C19HTT
SCHEMBL5753131 0.78 SMN1; SMN2 (0.41) SMN1; SMN2NPC1RAB9ACYP2C19HTT
SCHEMBL22589355 0.75 SMN1; SMN2 (0.49) SMN1; SMN2NPC1RAB9ACYP2C19HTT
SCHEMBL7529385 0.72 MAPK13 (0.48) GRIN2BTRPV4FAAHF2RCETP
SCHEMBL7468591 0.72 TRPC3 (0.42) SMN1; SMN2NPC1RAB9AGRIN2BTRPV4
SCHEMBL5761752 0.71 SMN1; SMN2 (0.42) SMN1; SMN2NPC1RAB9ACYP2C19CHRM2
SCHEMBL6170576 0.71 MAPK14 (0.49) GRIN2BTRPV4FAAHF2R
SCHEMBL6172304 0.71 MAPK14 (0.49) SMN1; SMN2NPC1RAB9AGRIN2BTRPV4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1131314-A4 COMPOUNDS HAVING CYTOKINE INHIBITORY ACTIVITY MERCK & CO INC (US) 2002-05-02 EP disclosed
US-6350744-B1 PYRMIDINE OR PYRIDINE DERIVATIVES; ANTIARTHRITIC AND ANTIINFLAMMATORY AGENTS; CACHEXIA TREATMENT; INTERLEUKIN AND TUMOR NECROSIS FACTOR INHIBITORS MERCK & CO., INC. 2002-02-26 US disclosed
EP-1131314-A1 COMPOUNDS HAVING CYTOKINE INHIBITORY ACTIVITY Merck & Co., Inc. (US) 2001-09-12 EP disclosed
WO-2000031065-A1 COMPOUNDS HAVING CYTOKINE INHIBITORY ACTIVITY MERCK & CO., INC. (US) 2000-06-02 WO disclosed